The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2015

Filed:

Sep. 17, 2014
Applicant:

Ibc Pharmaceuticals, Inc., Morris Plains, NJ (US);

Inventors:

Chien-Hsing Chang, Downingtown, PA (US);

David M. Goldenberg, Mendham, NJ (US);

William J. McBride, Boonton, NJ (US);

Edmund A. Rossi, Woodland Park, NJ (US);

Assignee:

IBC Pharmaceuticals, Inc., Morris Plains, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); C07K 16/28 (2006.01); C12N 9/12 (2006.01); C12N 9/96 (2006.01); A61K 31/00 (2006.01); B82Y 5/00 (2011.01); B82Y 10/00 (2011.01); B82Y 15/00 (2011.01); C07K 16/30 (2006.01); G01N 33/543 (2006.01); G01N 33/58 (2006.01); C07K 14/475 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/12 (2013.01); A61K 31/00 (2013.01); A61K 47/48415 (2013.01); A61K 47/48561 (2013.01); B82Y 5/00 (2013.01); B82Y 10/00 (2013.01); B82Y 15/00 (2013.01); C07K 14/475 (2013.01); C07K 16/2803 (2013.01); C07K 16/2881 (2013.01); C07K 16/2887 (2013.01); C07K 16/3007 (2013.01); C07K 16/3092 (2013.01); C12N 9/96 (2013.01); G01N 33/54353 (2013.01); G01N 33/588 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/55 (2013.01); C07K 2319/30 (2013.01); C07K 2319/35 (2013.01); C07K 2319/70 (2013.01); C07K 2319/74 (2013.01);
Abstract

The present invention concerns methods and compositions for making and using bioactive assemblies of defined compositions, which may have multiple functionalities and/or binding specificities. In particular embodiments, the bioactive assembly is formed using dock-and-lock (DNL) methodology, which takes advantage of the specific binding interaction between dimerization and docking domains (DDD) and anchoring domains (AD) to form the assembly. In various embodiments, one or more effectors may be attached to a DDD or AD sequence. Complementary AD or DDD sequences may be attached to an adaptor module that forms the core of the bioactive assembly, allowing formation of the assembly through the specific DDD/AD binding interactions. Such assemblies may be attached to a wide variety of effector moieties for treatment, detection and/or diagnosis of a disease, pathogen infection or other medical or veterinary condition.


Find Patent Forward Citations

Loading…